title: From HDACi to KDACi: we need to revisit non-epigenetic pathways affected by inhibiting lysine deacetylases in therapy.
authors: Department of Molecular Biology, BMC, LMU, Planegg-Martinsried, Germany.
authors: Axel
authors: 0000-0003-2993-8249
authors: A
authors: Imhof
authors: Department of Molecular Biology, BMC, LMU, Planegg-Martinsried, Germany.
authors: Shahaf
authors: S
authors: Peleg
mesh_terms: D000107:Acetylation; D044127:Epigenesis, Genetic; D056572:Histone Deacetylase Inhibitors / Q000627:therapeutic use*; D006655:Histone Deacetylases / Q000378:metabolism*; D006801:Humans; D008239:Lysine / Q000378:metabolism*
chemical_list: D056572:Histone Deacetylase Inhibitors; D006655:Histone Deacetylases; D008239:Lysine